Global Biosimilar and Biologics Supply, Demand and Key Producers, 2024-2030
The global Biosimilar and Biologics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Biosimilar and Biologics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilar and Biologics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar and Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilar and Biologics total production and demand, 2019-2030, (K Units)
Global Biosimilar and Biologics total production value, 2019-2030, (USD Million)
Global Biosimilar and Biologics production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Biosimilar and Biologics consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Biosimilar and Biologics domestic production, consumption, key domestic manufacturers and share
Global Biosimilar and Biologics production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Biosimilar and Biologics production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Biosimilar and Biologics production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Biosimilar and Biologics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Roche AG, AbbVie, Novartis AG, Merck, Bristol Myers Squibb, GSK, AstraZeneca and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosimilar and Biologics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Biosimilar and Biologics Market, By Region:
1. How big is the global Biosimilar and Biologics market?
2. What is the demand of the global Biosimilar and Biologics market?
3. What is the year over year growth of the global Biosimilar and Biologics market?
4. What is the production and production value of the global Biosimilar and Biologics market?
5. Who are the key producers in the global Biosimilar and Biologics market?
This report studies the global Biosimilar and Biologics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilar and Biologics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar and Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilar and Biologics total production and demand, 2019-2030, (K Units)
Global Biosimilar and Biologics total production value, 2019-2030, (USD Million)
Global Biosimilar and Biologics production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Biosimilar and Biologics consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Biosimilar and Biologics domestic production, consumption, key domestic manufacturers and share
Global Biosimilar and Biologics production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Biosimilar and Biologics production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Biosimilar and Biologics production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Biosimilar and Biologics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Roche AG, AbbVie, Novartis AG, Merck, Bristol Myers Squibb, GSK, AstraZeneca and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosimilar and Biologics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Biosimilar and Biologics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibody
- Vaccines
- Recombinant Insulin
- Growth Factors
- Immune Modulators
- Fusion Protein
- Erythoprotein
- Other
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Disorders
- Other
- Pfizer
- Roche AG
- AbbVie
- Novartis AG
- Merck
- Bristol Myers Squibb
- GSK
- AstraZeneca
- Eli Lilly
- Bayer
- Gilead Sciences
- Amgen
- Boehringer Ingelheim
- Novo Nordisk
- Viatris
- Johnson
- Sanofi Winthrop Industries
- Serum Institute of India
- Biocon
- Intas Pharmaceuticals
1. How big is the global Biosimilar and Biologics market?
2. What is the demand of the global Biosimilar and Biologics market?
3. What is the year over year growth of the global Biosimilar and Biologics market?
4. What is the production and production value of the global Biosimilar and Biologics market?
5. Who are the key producers in the global Biosimilar and Biologics market?
1 SUPPLY SUMMARY
1.1 Biosimilar and Biologics Introduction
1.2 World Biosimilar and Biologics Supply & Forecast
1.2.1 World Biosimilar and Biologics Production Value (2019 & 2023 & 2030)
1.2.2 World Biosimilar and Biologics Production (2019-2030)
1.2.3 World Biosimilar and Biologics Pricing Trends (2019-2030)
1.3 World Biosimilar and Biologics Production by Region (Based on Production Site)
1.3.1 World Biosimilar and Biologics Production Value by Region (2019-2030)
1.3.2 World Biosimilar and Biologics Production by Region (2019-2030)
1.3.3 World Biosimilar and Biologics Average Price by Region (2019-2030)
1.3.4 North America Biosimilar and Biologics Production (2019-2030)
1.3.5 Europe Biosimilar and Biologics Production (2019-2030)
1.3.6 China Biosimilar and Biologics Production (2019-2030)
1.3.7 Japan Biosimilar and Biologics Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosimilar and Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biosimilar and Biologics Major Market Trends
2 DEMAND SUMMARY
2.1 World Biosimilar and Biologics Demand (2019-2030)
2.2 World Biosimilar and Biologics Consumption by Region
2.2.1 World Biosimilar and Biologics Consumption by Region (2019-2024)
2.2.2 World Biosimilar and Biologics Consumption Forecast by Region (2025-2030)
2.3 United States Biosimilar and Biologics Consumption (2019-2030)
2.4 China Biosimilar and Biologics Consumption (2019-2030)
2.5 Europe Biosimilar and Biologics Consumption (2019-2030)
2.6 Japan Biosimilar and Biologics Consumption (2019-2030)
2.7 South Korea Biosimilar and Biologics Consumption (2019-2030)
2.8 ASEAN Biosimilar and Biologics Consumption (2019-2030)
2.9 India Biosimilar and Biologics Consumption (2019-2030)
3 WORLD BIOSIMILAR AND BIOLOGICS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biosimilar and Biologics Production Value by Manufacturer (2019-2024)
3.2 World Biosimilar and Biologics Production by Manufacturer (2019-2024)
3.3 World Biosimilar and Biologics Average Price by Manufacturer (2019-2024)
3.4 Biosimilar and Biologics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biosimilar and Biologics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biosimilar and Biologics in 2023
3.5.3 Global Concentration Ratios (CR8) for Biosimilar and Biologics in 2023
3.6 Biosimilar and Biologics Market: Overall Company Footprint Analysis
3.6.1 Biosimilar and Biologics Market: Region Footprint
3.6.2 Biosimilar and Biologics Market: Company Product Type Footprint
3.6.3 Biosimilar and Biologics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biosimilar and Biologics Production Value Comparison
4.1.1 United States VS China: Biosimilar and Biologics Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Biosimilar and Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Biosimilar and Biologics Production Comparison
4.2.1 United States VS China: Biosimilar and Biologics Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Biosimilar and Biologics Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Biosimilar and Biologics Consumption Comparison
4.3.1 United States VS China: Biosimilar and Biologics Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Biosimilar and Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Biosimilar and Biologics Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biosimilar and Biologics Production Value (2019-2024)
4.4.3 United States Based Manufacturers Biosimilar and Biologics Production (2019-2024)
4.5 China Based Biosimilar and Biologics Manufacturers and Market Share
4.5.1 China Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biosimilar and Biologics Production Value (2019-2024)
4.5.3 China Based Manufacturers Biosimilar and Biologics Production (2019-2024)
4.6 Rest of World Based Biosimilar and Biologics Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biosimilar and Biologics Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Biosimilar and Biologics Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosimilar and Biologics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Vaccines
5.2.3 Recombinant Insulin
5.2.4 Growth Factors
5.2.5 Immune Modulators
5.2.6 Fusion Protein
5.2.7 Erythoprotein
5.2.8 Other
5.3 Market Segment by Type
5.3.1 World Biosimilar and Biologics Production by Type (2019-2030)
5.3.2 World Biosimilar and Biologics Production Value by Type (2019-2030)
5.3.3 World Biosimilar and Biologics Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosimilar and Biologics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Autoimmune Diseases
6.2.2 Infectious Diseases
6.2.3 Cardiovascular Disorders
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Biosimilar and Biologics Production by Application (2019-2030)
6.3.2 World Biosimilar and Biologics Production Value by Application (2019-2030)
6.3.3 World Biosimilar and Biologics Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Biosimilar and Biologics Product and Services
7.1.4 Pfizer Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Roche AG
7.2.1 Roche AG Details
7.2.2 Roche AG Major Business
7.2.3 Roche AG Biosimilar and Biologics Product and Services
7.2.4 Roche AG Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Roche AG Recent Developments/Updates
7.2.6 Roche AG Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Biosimilar and Biologics Product and Services
7.3.4 AbbVie Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Biosimilar and Biologics Product and Services
7.4.4 Novartis AG Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Biosimilar and Biologics Product and Services
7.5.4 Merck Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Details
7.6.2 Bristol Myers Squibb Major Business
7.6.3 Bristol Myers Squibb Biosimilar and Biologics Product and Services
7.6.4 Bristol Myers Squibb Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bristol Myers Squibb Recent Developments/Updates
7.6.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.7 GSK
7.7.1 GSK Details
7.7.2 GSK Major Business
7.7.3 GSK Biosimilar and Biologics Product and Services
7.7.4 GSK Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 GSK Recent Developments/Updates
7.7.6 GSK Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Biosimilar and Biologics Product and Services
7.8.4 AstraZeneca Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Eli Lilly
7.9.1 Eli Lilly Details
7.9.2 Eli Lilly Major Business
7.9.3 Eli Lilly Biosimilar and Biologics Product and Services
7.9.4 Eli Lilly Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Eli Lilly Recent Developments/Updates
7.9.6 Eli Lilly Competitive Strengths & Weaknesses
7.10 Bayer
7.10.1 Bayer Details
7.10.2 Bayer Major Business
7.10.3 Bayer Biosimilar and Biologics Product and Services
7.10.4 Bayer Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Bayer Recent Developments/Updates
7.10.6 Bayer Competitive Strengths & Weaknesses
7.11 Gilead Sciences
7.11.1 Gilead Sciences Details
7.11.2 Gilead Sciences Major Business
7.11.3 Gilead Sciences Biosimilar and Biologics Product and Services
7.11.4 Gilead Sciences Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Gilead Sciences Recent Developments/Updates
7.11.6 Gilead Sciences Competitive Strengths & Weaknesses
7.12 Amgen
7.12.1 Amgen Details
7.12.2 Amgen Major Business
7.12.3 Amgen Biosimilar and Biologics Product and Services
7.12.4 Amgen Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Amgen Recent Developments/Updates
7.12.6 Amgen Competitive Strengths & Weaknesses
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Details
7.13.2 Boehringer Ingelheim Major Business
7.13.3 Boehringer Ingelheim Biosimilar and Biologics Product and Services
7.13.4 Boehringer Ingelheim Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Boehringer Ingelheim Recent Developments/Updates
7.13.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.14 Novo Nordisk
7.14.1 Novo Nordisk Details
7.14.2 Novo Nordisk Major Business
7.14.3 Novo Nordisk Biosimilar and Biologics Product and Services
7.14.4 Novo Nordisk Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Novo Nordisk Recent Developments/Updates
7.14.6 Novo Nordisk Competitive Strengths & Weaknesses
7.15 Viatris
7.15.1 Viatris Details
7.15.2 Viatris Major Business
7.15.3 Viatris Biosimilar and Biologics Product and Services
7.15.4 Viatris Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Viatris Recent Developments/Updates
7.15.6 Viatris Competitive Strengths & Weaknesses
7.16 Johnson
7.16.1 Johnson Details
7.16.2 Johnson Major Business
7.16.3 Johnson Biosimilar and Biologics Product and Services
7.16.4 Johnson Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Johnson Recent Developments/Updates
7.16.6 Johnson Competitive Strengths & Weaknesses
7.17 Sanofi Winthrop Industries
7.17.1 Sanofi Winthrop Industries Details
7.17.2 Sanofi Winthrop Industries Major Business
7.17.3 Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
7.17.4 Sanofi Winthrop Industries Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Sanofi Winthrop Industries Recent Developments/Updates
7.17.6 Sanofi Winthrop Industries Competitive Strengths & Weaknesses
7.18 Serum Institute of India
7.18.1 Serum Institute of India Details
7.18.2 Serum Institute of India Major Business
7.18.3 Serum Institute of India Biosimilar and Biologics Product and Services
7.18.4 Serum Institute of India Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Serum Institute of India Recent Developments/Updates
7.18.6 Serum Institute of India Competitive Strengths & Weaknesses
7.19 Biocon
7.19.1 Biocon Details
7.19.2 Biocon Major Business
7.19.3 Biocon Biosimilar and Biologics Product and Services
7.19.4 Biocon Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Biocon Recent Developments/Updates
7.19.6 Biocon Competitive Strengths & Weaknesses
7.20 Intas Pharmaceuticals
7.20.1 Intas Pharmaceuticals Details
7.20.2 Intas Pharmaceuticals Major Business
7.20.3 Intas Pharmaceuticals Biosimilar and Biologics Product and Services
7.20.4 Intas Pharmaceuticals Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Intas Pharmaceuticals Recent Developments/Updates
7.20.6 Intas Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosimilar and Biologics Industry Chain
8.2 Biosimilar and Biologics Upstream Analysis
8.2.1 Biosimilar and Biologics Core Raw Materials
8.2.2 Main Manufacturers of Biosimilar and Biologics Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biosimilar and Biologics Production Mode
8.6 Biosimilar and Biologics Procurement Model
8.7 Biosimilar and Biologics Industry Sales Model and Sales Channels
8.7.1 Biosimilar and Biologics Sales Model
8.7.2 Biosimilar and Biologics Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biosimilar and Biologics Introduction
1.2 World Biosimilar and Biologics Supply & Forecast
1.2.1 World Biosimilar and Biologics Production Value (2019 & 2023 & 2030)
1.2.2 World Biosimilar and Biologics Production (2019-2030)
1.2.3 World Biosimilar and Biologics Pricing Trends (2019-2030)
1.3 World Biosimilar and Biologics Production by Region (Based on Production Site)
1.3.1 World Biosimilar and Biologics Production Value by Region (2019-2030)
1.3.2 World Biosimilar and Biologics Production by Region (2019-2030)
1.3.3 World Biosimilar and Biologics Average Price by Region (2019-2030)
1.3.4 North America Biosimilar and Biologics Production (2019-2030)
1.3.5 Europe Biosimilar and Biologics Production (2019-2030)
1.3.6 China Biosimilar and Biologics Production (2019-2030)
1.3.7 Japan Biosimilar and Biologics Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosimilar and Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biosimilar and Biologics Major Market Trends
2 DEMAND SUMMARY
2.1 World Biosimilar and Biologics Demand (2019-2030)
2.2 World Biosimilar and Biologics Consumption by Region
2.2.1 World Biosimilar and Biologics Consumption by Region (2019-2024)
2.2.2 World Biosimilar and Biologics Consumption Forecast by Region (2025-2030)
2.3 United States Biosimilar and Biologics Consumption (2019-2030)
2.4 China Biosimilar and Biologics Consumption (2019-2030)
2.5 Europe Biosimilar and Biologics Consumption (2019-2030)
2.6 Japan Biosimilar and Biologics Consumption (2019-2030)
2.7 South Korea Biosimilar and Biologics Consumption (2019-2030)
2.8 ASEAN Biosimilar and Biologics Consumption (2019-2030)
2.9 India Biosimilar and Biologics Consumption (2019-2030)
3 WORLD BIOSIMILAR AND BIOLOGICS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biosimilar and Biologics Production Value by Manufacturer (2019-2024)
3.2 World Biosimilar and Biologics Production by Manufacturer (2019-2024)
3.3 World Biosimilar and Biologics Average Price by Manufacturer (2019-2024)
3.4 Biosimilar and Biologics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biosimilar and Biologics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biosimilar and Biologics in 2023
3.5.3 Global Concentration Ratios (CR8) for Biosimilar and Biologics in 2023
3.6 Biosimilar and Biologics Market: Overall Company Footprint Analysis
3.6.1 Biosimilar and Biologics Market: Region Footprint
3.6.2 Biosimilar and Biologics Market: Company Product Type Footprint
3.6.3 Biosimilar and Biologics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biosimilar and Biologics Production Value Comparison
4.1.1 United States VS China: Biosimilar and Biologics Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Biosimilar and Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Biosimilar and Biologics Production Comparison
4.2.1 United States VS China: Biosimilar and Biologics Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Biosimilar and Biologics Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Biosimilar and Biologics Consumption Comparison
4.3.1 United States VS China: Biosimilar and Biologics Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Biosimilar and Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Biosimilar and Biologics Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biosimilar and Biologics Production Value (2019-2024)
4.4.3 United States Based Manufacturers Biosimilar and Biologics Production (2019-2024)
4.5 China Based Biosimilar and Biologics Manufacturers and Market Share
4.5.1 China Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biosimilar and Biologics Production Value (2019-2024)
4.5.3 China Based Manufacturers Biosimilar and Biologics Production (2019-2024)
4.6 Rest of World Based Biosimilar and Biologics Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biosimilar and Biologics Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Biosimilar and Biologics Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosimilar and Biologics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Vaccines
5.2.3 Recombinant Insulin
5.2.4 Growth Factors
5.2.5 Immune Modulators
5.2.6 Fusion Protein
5.2.7 Erythoprotein
5.2.8 Other
5.3 Market Segment by Type
5.3.1 World Biosimilar and Biologics Production by Type (2019-2030)
5.3.2 World Biosimilar and Biologics Production Value by Type (2019-2030)
5.3.3 World Biosimilar and Biologics Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosimilar and Biologics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Autoimmune Diseases
6.2.2 Infectious Diseases
6.2.3 Cardiovascular Disorders
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Biosimilar and Biologics Production by Application (2019-2030)
6.3.2 World Biosimilar and Biologics Production Value by Application (2019-2030)
6.3.3 World Biosimilar and Biologics Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Biosimilar and Biologics Product and Services
7.1.4 Pfizer Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Roche AG
7.2.1 Roche AG Details
7.2.2 Roche AG Major Business
7.2.3 Roche AG Biosimilar and Biologics Product and Services
7.2.4 Roche AG Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Roche AG Recent Developments/Updates
7.2.6 Roche AG Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Biosimilar and Biologics Product and Services
7.3.4 AbbVie Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Biosimilar and Biologics Product and Services
7.4.4 Novartis AG Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Biosimilar and Biologics Product and Services
7.5.4 Merck Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Details
7.6.2 Bristol Myers Squibb Major Business
7.6.3 Bristol Myers Squibb Biosimilar and Biologics Product and Services
7.6.4 Bristol Myers Squibb Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bristol Myers Squibb Recent Developments/Updates
7.6.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.7 GSK
7.7.1 GSK Details
7.7.2 GSK Major Business
7.7.3 GSK Biosimilar and Biologics Product and Services
7.7.4 GSK Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 GSK Recent Developments/Updates
7.7.6 GSK Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Biosimilar and Biologics Product and Services
7.8.4 AstraZeneca Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Eli Lilly
7.9.1 Eli Lilly Details
7.9.2 Eli Lilly Major Business
7.9.3 Eli Lilly Biosimilar and Biologics Product and Services
7.9.4 Eli Lilly Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Eli Lilly Recent Developments/Updates
7.9.6 Eli Lilly Competitive Strengths & Weaknesses
7.10 Bayer
7.10.1 Bayer Details
7.10.2 Bayer Major Business
7.10.3 Bayer Biosimilar and Biologics Product and Services
7.10.4 Bayer Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Bayer Recent Developments/Updates
7.10.6 Bayer Competitive Strengths & Weaknesses
7.11 Gilead Sciences
7.11.1 Gilead Sciences Details
7.11.2 Gilead Sciences Major Business
7.11.3 Gilead Sciences Biosimilar and Biologics Product and Services
7.11.4 Gilead Sciences Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Gilead Sciences Recent Developments/Updates
7.11.6 Gilead Sciences Competitive Strengths & Weaknesses
7.12 Amgen
7.12.1 Amgen Details
7.12.2 Amgen Major Business
7.12.3 Amgen Biosimilar and Biologics Product and Services
7.12.4 Amgen Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Amgen Recent Developments/Updates
7.12.6 Amgen Competitive Strengths & Weaknesses
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Details
7.13.2 Boehringer Ingelheim Major Business
7.13.3 Boehringer Ingelheim Biosimilar and Biologics Product and Services
7.13.4 Boehringer Ingelheim Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Boehringer Ingelheim Recent Developments/Updates
7.13.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.14 Novo Nordisk
7.14.1 Novo Nordisk Details
7.14.2 Novo Nordisk Major Business
7.14.3 Novo Nordisk Biosimilar and Biologics Product and Services
7.14.4 Novo Nordisk Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Novo Nordisk Recent Developments/Updates
7.14.6 Novo Nordisk Competitive Strengths & Weaknesses
7.15 Viatris
7.15.1 Viatris Details
7.15.2 Viatris Major Business
7.15.3 Viatris Biosimilar and Biologics Product and Services
7.15.4 Viatris Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Viatris Recent Developments/Updates
7.15.6 Viatris Competitive Strengths & Weaknesses
7.16 Johnson
7.16.1 Johnson Details
7.16.2 Johnson Major Business
7.16.3 Johnson Biosimilar and Biologics Product and Services
7.16.4 Johnson Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Johnson Recent Developments/Updates
7.16.6 Johnson Competitive Strengths & Weaknesses
7.17 Sanofi Winthrop Industries
7.17.1 Sanofi Winthrop Industries Details
7.17.2 Sanofi Winthrop Industries Major Business
7.17.3 Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
7.17.4 Sanofi Winthrop Industries Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Sanofi Winthrop Industries Recent Developments/Updates
7.17.6 Sanofi Winthrop Industries Competitive Strengths & Weaknesses
7.18 Serum Institute of India
7.18.1 Serum Institute of India Details
7.18.2 Serum Institute of India Major Business
7.18.3 Serum Institute of India Biosimilar and Biologics Product and Services
7.18.4 Serum Institute of India Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Serum Institute of India Recent Developments/Updates
7.18.6 Serum Institute of India Competitive Strengths & Weaknesses
7.19 Biocon
7.19.1 Biocon Details
7.19.2 Biocon Major Business
7.19.3 Biocon Biosimilar and Biologics Product and Services
7.19.4 Biocon Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Biocon Recent Developments/Updates
7.19.6 Biocon Competitive Strengths & Weaknesses
7.20 Intas Pharmaceuticals
7.20.1 Intas Pharmaceuticals Details
7.20.2 Intas Pharmaceuticals Major Business
7.20.3 Intas Pharmaceuticals Biosimilar and Biologics Product and Services
7.20.4 Intas Pharmaceuticals Biosimilar and Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Intas Pharmaceuticals Recent Developments/Updates
7.20.6 Intas Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosimilar and Biologics Industry Chain
8.2 Biosimilar and Biologics Upstream Analysis
8.2.1 Biosimilar and Biologics Core Raw Materials
8.2.2 Main Manufacturers of Biosimilar and Biologics Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biosimilar and Biologics Production Mode
8.6 Biosimilar and Biologics Procurement Model
8.7 Biosimilar and Biologics Industry Sales Model and Sales Channels
8.7.1 Biosimilar and Biologics Sales Model
8.7.2 Biosimilar and Biologics Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biosimilar and Biologics Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Biosimilar and Biologics Production Value by Region (2019-2024) & (USD Million)
Table 3. World Biosimilar and Biologics Production Value by Region (2025-2030) & (USD Million)
Table 4. World Biosimilar and Biologics Production Value Market Share by Region (2019-2024)
Table 5. World Biosimilar and Biologics Production Value Market Share by Region (2025-2030)
Table 6. World Biosimilar and Biologics Production by Region (2019-2024) & (K Units)
Table 7. World Biosimilar and Biologics Production by Region (2025-2030) & (K Units)
Table 8. World Biosimilar and Biologics Production Market Share by Region (2019-2024)
Table 9. World Biosimilar and Biologics Production Market Share by Region (2025-2030)
Table 10. World Biosimilar and Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Biosimilar and Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Biosimilar and Biologics Major Market Trends
Table 13. World Biosimilar and Biologics Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Biosimilar and Biologics Consumption by Region (2019-2024) & (K Units)
Table 15. World Biosimilar and Biologics Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Biosimilar and Biologics Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Biosimilar and Biologics Producers in 2023
Table 18. World Biosimilar and Biologics Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Biosimilar and Biologics Producers in 2023
Table 20. World Biosimilar and Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Biosimilar and Biologics Company Evaluation Quadrant
Table 22. World Biosimilar and Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Biosimilar and Biologics Production Site of Key Manufacturer
Table 24. Biosimilar and Biologics Market: Company Product Type Footprint
Table 25. Biosimilar and Biologics Market: Company Product Application Footprint
Table 26. Biosimilar and Biologics Competitive Factors
Table 27. Biosimilar and Biologics New Entrant and Capacity Expansion Plans
Table 28. Biosimilar and Biologics Mergers & Acquisitions Activity
Table 29. United States VS China Biosimilar and Biologics Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Biosimilar and Biologics Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Biosimilar and Biologics Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biosimilar and Biologics Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Biosimilar and Biologics Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Biosimilar and Biologics Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Biosimilar and Biologics Production Market Share (2019-2024)
Table 37. China Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biosimilar and Biologics Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Biosimilar and Biologics Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Biosimilar and Biologics Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Biosimilar and Biologics Production Market Share (2019-2024)
Table 42. Rest of World Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biosimilar and Biologics Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Biosimilar and Biologics Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Biosimilar and Biologics Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Biosimilar and Biologics Production Market Share (2019-2024)
Table 47. World Biosimilar and Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Biosimilar and Biologics Production by Type (2019-2024) & (K Units)
Table 49. World Biosimilar and Biologics Production by Type (2025-2030) & (K Units)
Table 50. World Biosimilar and Biologics Production Value by Type (2019-2024) & (USD Million)
Table 51. World Biosimilar and Biologics Production Value by Type (2025-2030) & (USD Million)
Table 52. World Biosimilar and Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Biosimilar and Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Biosimilar and Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Biosimilar and Biologics Production by Application (2019-2024) & (K Units)
Table 56. World Biosimilar and Biologics Production by Application (2025-2030) & (K Units)
Table 57. World Biosimilar and Biologics Production Value by Application (2019-2024) & (USD Million)
Table 58. World Biosimilar and Biologics Production Value by Application (2025-2030) & (USD Million)
Table 59. World Biosimilar and Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Biosimilar and Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Biosimilar and Biologics Product and Services
Table 64. Pfizer Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Roche AG Basic Information, Manufacturing Base and Competitors
Table 68. Roche AG Major Business
Table 69. Roche AG Biosimilar and Biologics Product and Services
Table 70. Roche AG Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Roche AG Recent Developments/Updates
Table 72. Roche AG Competitive Strengths & Weaknesses
Table 73. AbbVie Basic Information, Manufacturing Base and Competitors
Table 74. AbbVie Major Business
Table 75. AbbVie Biosimilar and Biologics Product and Services
Table 76. AbbVie Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AbbVie Recent Developments/Updates
Table 78. AbbVie Competitive Strengths & Weaknesses
Table 79. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 80. Novartis AG Major Business
Table 81. Novartis AG Biosimilar and Biologics Product and Services
Table 82. Novartis AG Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis AG Recent Developments/Updates
Table 84. Novartis AG Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Biosimilar and Biologics Product and Services
Table 88. Merck Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol Myers Squibb Major Business
Table 93. Bristol Myers Squibb Biosimilar and Biologics Product and Services
Table 94. Bristol Myers Squibb Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bristol Myers Squibb Recent Developments/Updates
Table 96. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 97. GSK Basic Information, Manufacturing Base and Competitors
Table 98. GSK Major Business
Table 99. GSK Biosimilar and Biologics Product and Services
Table 100. GSK Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. GSK Recent Developments/Updates
Table 102. GSK Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Biosimilar and Biologics Product and Services
Table 106. AstraZeneca Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 110. Eli Lilly Major Business
Table 111. Eli Lilly Biosimilar and Biologics Product and Services
Table 112. Eli Lilly Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Eli Lilly Recent Developments/Updates
Table 114. Eli Lilly Competitive Strengths & Weaknesses
Table 115. Bayer Basic Information, Manufacturing Base and Competitors
Table 116. Bayer Major Business
Table 117. Bayer Biosimilar and Biologics Product and Services
Table 118. Bayer Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Bayer Recent Developments/Updates
Table 120. Bayer Competitive Strengths & Weaknesses
Table 121. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 122. Gilead Sciences Major Business
Table 123. Gilead Sciences Biosimilar and Biologics Product and Services
Table 124. Gilead Sciences Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Gilead Sciences Recent Developments/Updates
Table 126. Gilead Sciences Competitive Strengths & Weaknesses
Table 127. Amgen Basic Information, Manufacturing Base and Competitors
Table 128. Amgen Major Business
Table 129. Amgen Biosimilar and Biologics Product and Services
Table 130. Amgen Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Amgen Recent Developments/Updates
Table 132. Amgen Competitive Strengths & Weaknesses
Table 133. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 134. Boehringer Ingelheim Major Business
Table 135. Boehringer Ingelheim Biosimilar and Biologics Product and Services
Table 136. Boehringer Ingelheim Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Boehringer Ingelheim Recent Developments/Updates
Table 138. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 139. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 140. Novo Nordisk Major Business
Table 141. Novo Nordisk Biosimilar and Biologics Product and Services
Table 142. Novo Nordisk Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Novo Nordisk Recent Developments/Updates
Table 144. Novo Nordisk Competitive Strengths & Weaknesses
Table 145. Viatris Basic Information, Manufacturing Base and Competitors
Table 146. Viatris Major Business
Table 147. Viatris Biosimilar and Biologics Product and Services
Table 148. Viatris Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Viatris Recent Developments/Updates
Table 150. Viatris Competitive Strengths & Weaknesses
Table 151. Johnson Basic Information, Manufacturing Base and Competitors
Table 152. Johnson Major Business
Table 153. Johnson Biosimilar and Biologics Product and Services
Table 154. Johnson Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Johnson Recent Developments/Updates
Table 156. Johnson Competitive Strengths & Weaknesses
Table 157. Sanofi Winthrop Industries Basic Information, Manufacturing Base and Competitors
Table 158. Sanofi Winthrop Industries Major Business
Table 159. Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
Table 160. Sanofi Winthrop Industries Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Sanofi Winthrop Industries Recent Developments/Updates
Table 162. Sanofi Winthrop Industries Competitive Strengths & Weaknesses
Table 163. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 164. Serum Institute of India Major Business
Table 165. Serum Institute of India Biosimilar and Biologics Product and Services
Table 166. Serum Institute of India Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Serum Institute of India Recent Developments/Updates
Table 168. Serum Institute of India Competitive Strengths & Weaknesses
Table 169. Biocon Basic Information, Manufacturing Base and Competitors
Table 170. Biocon Major Business
Table 171. Biocon Biosimilar and Biologics Product and Services
Table 172. Biocon Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Biocon Recent Developments/Updates
Table 174. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 175. Intas Pharmaceuticals Major Business
Table 176. Intas Pharmaceuticals Biosimilar and Biologics Product and Services
Table 177. Intas Pharmaceuticals Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 178. Global Key Players of Biosimilar and Biologics Upstream (Raw Materials)
Table 179. Biosimilar and Biologics Typical Customers
Table 180. Biosimilar and Biologics Typical Distributors
LIST OF FIGURE
Figure 1. Biosimilar and Biologics Picture
Figure 2. World Biosimilar and Biologics Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Biosimilar and Biologics Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 5. World Biosimilar and Biologics Average Price (2019-2030) & (US$/Unit)
Figure 6. World Biosimilar and Biologics Production Value Market Share by Region (2019-2030)
Figure 7. World Biosimilar and Biologics Production Market Share by Region (2019-2030)
Figure 8. North America Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 9. Europe Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 10. China Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 11. Japan Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 12. Biosimilar and Biologics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 15. World Biosimilar and Biologics Consumption Market Share by Region (2019-2030)
Figure 16. United States Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 17. China Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 18. Europe Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 19. Japan Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 20. South Korea Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 22. India Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Biosimilar and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biosimilar and Biologics Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biosimilar and Biologics Markets in 2023
Figure 26. United States VS China: Biosimilar and Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Biosimilar and Biologics Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Biosimilar and Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Biosimilar and Biologics Production Market Share 2023
Figure 30. China Based Manufacturers Biosimilar and Biologics Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Biosimilar and Biologics Production Market Share 2023
Figure 32. World Biosimilar and Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Biosimilar and Biologics Production Value Market Share by Type in 2023
Figure 34. Monoclonal Antibody
Figure 35. Vaccines
Figure 36. Recombinant Insulin
Figure 37. Growth Factors
Figure 38. Immune Modulators
Figure 39. Fusion Protein
Figure 40. Erythoprotein
Figure 41. Other
Figure 42. World Biosimilar and Biologics Production Market Share by Type (2019-2030)
Figure 43. World Biosimilar and Biologics Production Value Market Share by Type (2019-2030)
Figure 44. World Biosimilar and Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 45. World Biosimilar and Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 46. World Biosimilar and Biologics Production Value Market Share by Application in 2023
Figure 47. Autoimmune Diseases
Figure 48. Infectious Diseases
Figure 49. Cardiovascular Disorders
Figure 50. Other
Figure 51. World Biosimilar and Biologics Production Market Share by Application (2019-2030)
Figure 52. World Biosimilar and Biologics Production Value Market Share by Application (2019-2030)
Figure 53. World Biosimilar and Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 54. Biosimilar and Biologics Industry Chain
Figure 55. Biosimilar and Biologics Procurement Model
Figure 56. Biosimilar and Biologics Sales Model
Figure 57. Biosimilar and Biologics Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
Table 1. World Biosimilar and Biologics Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Biosimilar and Biologics Production Value by Region (2019-2024) & (USD Million)
Table 3. World Biosimilar and Biologics Production Value by Region (2025-2030) & (USD Million)
Table 4. World Biosimilar and Biologics Production Value Market Share by Region (2019-2024)
Table 5. World Biosimilar and Biologics Production Value Market Share by Region (2025-2030)
Table 6. World Biosimilar and Biologics Production by Region (2019-2024) & (K Units)
Table 7. World Biosimilar and Biologics Production by Region (2025-2030) & (K Units)
Table 8. World Biosimilar and Biologics Production Market Share by Region (2019-2024)
Table 9. World Biosimilar and Biologics Production Market Share by Region (2025-2030)
Table 10. World Biosimilar and Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Biosimilar and Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Biosimilar and Biologics Major Market Trends
Table 13. World Biosimilar and Biologics Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Biosimilar and Biologics Consumption by Region (2019-2024) & (K Units)
Table 15. World Biosimilar and Biologics Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Biosimilar and Biologics Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Biosimilar and Biologics Producers in 2023
Table 18. World Biosimilar and Biologics Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Biosimilar and Biologics Producers in 2023
Table 20. World Biosimilar and Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Biosimilar and Biologics Company Evaluation Quadrant
Table 22. World Biosimilar and Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Biosimilar and Biologics Production Site of Key Manufacturer
Table 24. Biosimilar and Biologics Market: Company Product Type Footprint
Table 25. Biosimilar and Biologics Market: Company Product Application Footprint
Table 26. Biosimilar and Biologics Competitive Factors
Table 27. Biosimilar and Biologics New Entrant and Capacity Expansion Plans
Table 28. Biosimilar and Biologics Mergers & Acquisitions Activity
Table 29. United States VS China Biosimilar and Biologics Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Biosimilar and Biologics Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Biosimilar and Biologics Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biosimilar and Biologics Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Biosimilar and Biologics Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Biosimilar and Biologics Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Biosimilar and Biologics Production Market Share (2019-2024)
Table 37. China Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biosimilar and Biologics Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Biosimilar and Biologics Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Biosimilar and Biologics Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Biosimilar and Biologics Production Market Share (2019-2024)
Table 42. Rest of World Based Biosimilar and Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biosimilar and Biologics Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Biosimilar and Biologics Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Biosimilar and Biologics Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Biosimilar and Biologics Production Market Share (2019-2024)
Table 47. World Biosimilar and Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Biosimilar and Biologics Production by Type (2019-2024) & (K Units)
Table 49. World Biosimilar and Biologics Production by Type (2025-2030) & (K Units)
Table 50. World Biosimilar and Biologics Production Value by Type (2019-2024) & (USD Million)
Table 51. World Biosimilar and Biologics Production Value by Type (2025-2030) & (USD Million)
Table 52. World Biosimilar and Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Biosimilar and Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Biosimilar and Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Biosimilar and Biologics Production by Application (2019-2024) & (K Units)
Table 56. World Biosimilar and Biologics Production by Application (2025-2030) & (K Units)
Table 57. World Biosimilar and Biologics Production Value by Application (2019-2024) & (USD Million)
Table 58. World Biosimilar and Biologics Production Value by Application (2025-2030) & (USD Million)
Table 59. World Biosimilar and Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Biosimilar and Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Biosimilar and Biologics Product and Services
Table 64. Pfizer Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Roche AG Basic Information, Manufacturing Base and Competitors
Table 68. Roche AG Major Business
Table 69. Roche AG Biosimilar and Biologics Product and Services
Table 70. Roche AG Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Roche AG Recent Developments/Updates
Table 72. Roche AG Competitive Strengths & Weaknesses
Table 73. AbbVie Basic Information, Manufacturing Base and Competitors
Table 74. AbbVie Major Business
Table 75. AbbVie Biosimilar and Biologics Product and Services
Table 76. AbbVie Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AbbVie Recent Developments/Updates
Table 78. AbbVie Competitive Strengths & Weaknesses
Table 79. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 80. Novartis AG Major Business
Table 81. Novartis AG Biosimilar and Biologics Product and Services
Table 82. Novartis AG Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis AG Recent Developments/Updates
Table 84. Novartis AG Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Biosimilar and Biologics Product and Services
Table 88. Merck Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol Myers Squibb Major Business
Table 93. Bristol Myers Squibb Biosimilar and Biologics Product and Services
Table 94. Bristol Myers Squibb Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bristol Myers Squibb Recent Developments/Updates
Table 96. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 97. GSK Basic Information, Manufacturing Base and Competitors
Table 98. GSK Major Business
Table 99. GSK Biosimilar and Biologics Product and Services
Table 100. GSK Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. GSK Recent Developments/Updates
Table 102. GSK Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Biosimilar and Biologics Product and Services
Table 106. AstraZeneca Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 110. Eli Lilly Major Business
Table 111. Eli Lilly Biosimilar and Biologics Product and Services
Table 112. Eli Lilly Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Eli Lilly Recent Developments/Updates
Table 114. Eli Lilly Competitive Strengths & Weaknesses
Table 115. Bayer Basic Information, Manufacturing Base and Competitors
Table 116. Bayer Major Business
Table 117. Bayer Biosimilar and Biologics Product and Services
Table 118. Bayer Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Bayer Recent Developments/Updates
Table 120. Bayer Competitive Strengths & Weaknesses
Table 121. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 122. Gilead Sciences Major Business
Table 123. Gilead Sciences Biosimilar and Biologics Product and Services
Table 124. Gilead Sciences Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Gilead Sciences Recent Developments/Updates
Table 126. Gilead Sciences Competitive Strengths & Weaknesses
Table 127. Amgen Basic Information, Manufacturing Base and Competitors
Table 128. Amgen Major Business
Table 129. Amgen Biosimilar and Biologics Product and Services
Table 130. Amgen Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Amgen Recent Developments/Updates
Table 132. Amgen Competitive Strengths & Weaknesses
Table 133. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 134. Boehringer Ingelheim Major Business
Table 135. Boehringer Ingelheim Biosimilar and Biologics Product and Services
Table 136. Boehringer Ingelheim Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Boehringer Ingelheim Recent Developments/Updates
Table 138. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 139. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 140. Novo Nordisk Major Business
Table 141. Novo Nordisk Biosimilar and Biologics Product and Services
Table 142. Novo Nordisk Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Novo Nordisk Recent Developments/Updates
Table 144. Novo Nordisk Competitive Strengths & Weaknesses
Table 145. Viatris Basic Information, Manufacturing Base and Competitors
Table 146. Viatris Major Business
Table 147. Viatris Biosimilar and Biologics Product and Services
Table 148. Viatris Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Viatris Recent Developments/Updates
Table 150. Viatris Competitive Strengths & Weaknesses
Table 151. Johnson Basic Information, Manufacturing Base and Competitors
Table 152. Johnson Major Business
Table 153. Johnson Biosimilar and Biologics Product and Services
Table 154. Johnson Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Johnson Recent Developments/Updates
Table 156. Johnson Competitive Strengths & Weaknesses
Table 157. Sanofi Winthrop Industries Basic Information, Manufacturing Base and Competitors
Table 158. Sanofi Winthrop Industries Major Business
Table 159. Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
Table 160. Sanofi Winthrop Industries Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Sanofi Winthrop Industries Recent Developments/Updates
Table 162. Sanofi Winthrop Industries Competitive Strengths & Weaknesses
Table 163. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 164. Serum Institute of India Major Business
Table 165. Serum Institute of India Biosimilar and Biologics Product and Services
Table 166. Serum Institute of India Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Serum Institute of India Recent Developments/Updates
Table 168. Serum Institute of India Competitive Strengths & Weaknesses
Table 169. Biocon Basic Information, Manufacturing Base and Competitors
Table 170. Biocon Major Business
Table 171. Biocon Biosimilar and Biologics Product and Services
Table 172. Biocon Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Biocon Recent Developments/Updates
Table 174. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 175. Intas Pharmaceuticals Major Business
Table 176. Intas Pharmaceuticals Biosimilar and Biologics Product and Services
Table 177. Intas Pharmaceuticals Biosimilar and Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 178. Global Key Players of Biosimilar and Biologics Upstream (Raw Materials)
Table 179. Biosimilar and Biologics Typical Customers
Table 180. Biosimilar and Biologics Typical Distributors
LIST OF FIGURE
Figure 1. Biosimilar and Biologics Picture
Figure 2. World Biosimilar and Biologics Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Biosimilar and Biologics Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 5. World Biosimilar and Biologics Average Price (2019-2030) & (US$/Unit)
Figure 6. World Biosimilar and Biologics Production Value Market Share by Region (2019-2030)
Figure 7. World Biosimilar and Biologics Production Market Share by Region (2019-2030)
Figure 8. North America Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 9. Europe Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 10. China Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 11. Japan Biosimilar and Biologics Production (2019-2030) & (K Units)
Figure 12. Biosimilar and Biologics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 15. World Biosimilar and Biologics Consumption Market Share by Region (2019-2030)
Figure 16. United States Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 17. China Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 18. Europe Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 19. Japan Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 20. South Korea Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 22. India Biosimilar and Biologics Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Biosimilar and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biosimilar and Biologics Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biosimilar and Biologics Markets in 2023
Figure 26. United States VS China: Biosimilar and Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Biosimilar and Biologics Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Biosimilar and Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Biosimilar and Biologics Production Market Share 2023
Figure 30. China Based Manufacturers Biosimilar and Biologics Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Biosimilar and Biologics Production Market Share 2023
Figure 32. World Biosimilar and Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Biosimilar and Biologics Production Value Market Share by Type in 2023
Figure 34. Monoclonal Antibody
Figure 35. Vaccines
Figure 36. Recombinant Insulin
Figure 37. Growth Factors
Figure 38. Immune Modulators
Figure 39. Fusion Protein
Figure 40. Erythoprotein
Figure 41. Other
Figure 42. World Biosimilar and Biologics Production Market Share by Type (2019-2030)
Figure 43. World Biosimilar and Biologics Production Value Market Share by Type (2019-2030)
Figure 44. World Biosimilar and Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 45. World Biosimilar and Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 46. World Biosimilar and Biologics Production Value Market Share by Application in 2023
Figure 47. Autoimmune Diseases
Figure 48. Infectious Diseases
Figure 49. Cardiovascular Disorders
Figure 50. Other
Figure 51. World Biosimilar and Biologics Production Market Share by Application (2019-2030)
Figure 52. World Biosimilar and Biologics Production Value Market Share by Application (2019-2030)
Figure 53. World Biosimilar and Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 54. Biosimilar and Biologics Industry Chain
Figure 55. Biosimilar and Biologics Procurement Model
Figure 56. Biosimilar and Biologics Sales Model
Figure 57. Biosimilar and Biologics Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
